Huawei advances Continuous Glucose Monitoring (CGM) device launch preparations, says leaker

Huawei advances Continuous Glucose Monitoring (CGM) device launch preparations, says leaker

News

Huawei advances Continuous Glucose Monitoring (CGM) device launch preparations, says leaker

Huawei Watch 4 series high blood sugar

Huawei could soon release a continuous blood glucose monitoring (CGM) device and has already completed the medical certification, according to tipster FixedFocusDigital.

He Gang, CEO of the consumer business unit, confirmed in September that Huawei is developing a blood sugar monitoring device using years of research and development.

Huawei has been testing the blood sugar technology in consumer smartwatches for the past three years. The Huawei Watch 4 series features a non-invasive high blood sugar assessment feature based on continuous blood pressure spike monitoring.

However, the Watch 6 series installed a dedicated Blood Sugar health study app that asks users to measure blood sugar voluntarily.

It appears Huawei is ready to launch a real solution, just like heart rate ECG and heart rate measurement, as the upcoming device has completed Class III medical device certification.

Huawei blood sugar monitoring GCM device

Source – Fixed Focus Digital (Weibo)

This certification applies to China’s high-risk medical devices such as cardiac stents, artificial joints, and continuous glucose monitoring systems. It requires strict quality control and management capabilities to ensure safety and effectiveness through rigorous clinical trials.

CGM technology is designed for people with diabetes, integrated into wearables to track blood sugar levels 24 hours a day using a sensor. This tech sidelines invasive procedures like fingersticks.

According to Cleveland Clinic, such devices rely on interstitial fluid, which comes from substances that leak out of the blood capillaries. One of these substances is glucose AKA sugar. The sensor tracks the interstitial fluid to measure the glucose.

Since glucose first enters the bloodstream and then leaks into interstitial fluid, CGM blood glucose readings might lag a few minutes behind a fingerstick blood glucose reading.

CGM relies on these continuous readings to alert the user about abnormal levels through a connected device like a smartphone. However, traditional CGM uses a separate sensor on the arm or belly to measure the glucose levels. This part looks a little complicated for smartwatches.

Huawei has been testing the technology for a while, and a breakthrough could bring this solution to consumers with a smart wearable. For now, Huawei hasn’t officially launched the device.


Source: Read original article